Literature DB >> 10994263

Tobacco industry tactics for resisting public policy on health.

Y Saloojee1, E Dagli.   

Abstract

The tactics used by the tobacco industry to resist government regulation of its products include conducting public relations campaigns, buying scientific and other expertise to create controversy about established facts, funding political parties, hiring lobbyists to influence policy, using front groups and allied industries to oppose tobacco control measures, pre-empting strong legislation by pressing for the adoption of voluntary codes or weaker laws, and corrupting public officials. Formerly secret internal tobacco industry documents provide evidence of a 50-year conspiracy to "resist smoking restrictions, restore smoker confidence and preserve product liability defence". The documents reveal industry-wide collusion on legal, political and socially important issues to the tobacco industry and clearly demonstrate that the industry is not disposed to act ethically or responsibly. Societal action is therefore required to ensure that the public health takes precedence over corporate profits. Recommendations for reducing the political influence of the tobacco industry include the following. Every tobacco company in every market should publicly disclose what it knew about the addictiveness and harm caused by tobacco, when it obtained this information, and what it did about it. The industry should be required to guarantee internationally recognized basic consumer rights to its customers. Trade associations and other industry groupings established to deceive the public should be disbanded. These recommendations should be incorporated into WHO's Framework Convention on Tobacco Control.

Entities:  

Mesh:

Year:  2000        PMID: 10994263      PMCID: PMC2560805     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  70 in total

1.  Second hand smoke and risk assessment: what was in it for the tobacco industry?

Authors:  N Hirschhorn; S A Bialous
Journal:  Tob Control       Date:  2001-12       Impact factor: 7.552

2.  Through tobacco industry eyes: civil society and the FCTC process from Philip Morris and British American Tobacco's perspectives.

Authors:  Mariaelena Gonzalez; Lawrence W Green; Stanton A Glantz
Journal:  Tob Control       Date:  2011-06-02       Impact factor: 7.552

3.  Development of a model of the tobacco industry's interference with tobacco control programmes.

Authors:  W M K Trochim; F A Stillman; P I Clark; C L Schmitt
Journal:  Tob Control       Date:  2003-06       Impact factor: 7.552

4.  [Why must we support the laws on smoke free zones?].

Authors:  César Minué Lorenzo; Eduardo Olano Espinosa; José Vizcaíno Sánchez-Rodrigo
Journal:  Aten Primaria       Date:  2010-04-07       Impact factor: 1.137

5.  Challenging Ties between State and Tobacco Industry: Advocacy Lessons from India.

Authors:  Upendra Bhojani; Vidya Venkataraman; Bheemaray Manganawar
Journal:  Health Promot Perspect       Date:  2013-06-30

Review 6.  "A phony way to show sincerity, as we all well know": tobacco industry lobbying against tobacco control in Hong Kong.

Authors:  J Knight; S Chapman
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

7.  Alcohol misuse, public health, and public policy.

Authors:  Soumen Sengupta; Lesley Hoyle
Journal:  BMJ       Date:  2005-06-11

8.  The evolution of health warning labels on cigarette packs: the role of precedents, and tobacco industry strategies to block diffusion.

Authors:  Heikki Hiilamo; Eric Crosbie; Stanton A Glantz
Journal:  Tob Control       Date:  2012-10-23       Impact factor: 7.552

9.  Tobacco industry attempts to counter the World Bank report Curbing the Epidemic and obstruct the WHO framework convention on tobacco control.

Authors:  Hadii M Mamudu; Ross Hammond; Stanton Glantz
Journal:  Soc Sci Med       Date:  2008-10-22       Impact factor: 4.634

10.  Tobacco Industry Strategies to Obstruct the FCTC in Argentina.

Authors:  Raul Mejia; Verónica Schoj; Joaquin Barnoya; María Laura Flores; Eliseo J Pérez-Stable
Journal:  CVD Prev Control       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.